NCT04035733Phase 2Completed

rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

Study sponsor: AKARI Therapeutics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2020-03-12Actual
Enrollment · participants9Actual
Source updated2025-04-22Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.